OT04 | GOLSEEK‐1: A PHASE 3, DOUBLE‐BLIND, RANDOMIZED STUDY OF GOLCADOMIDE + R‐CHOP VERSUS PLACEBO + R‐CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK, LARGE B‐CELL LYMPHOMA
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
CC‐99282 plus R‐CHOP in patients (pts) with previously untreated aggressive B‐cell lymphoma (a‐BCL): early safety and efficacy results from a phase 1b study